Purified streptococcal mitogens (SMs) including erythrogenic exotoxin were compared with phytohemagglutinin (PHA) for their ability to sustain lymphadenopathy-associated virus (LAV) replication after the stimulation of normal human peripheral blood mononuclear cells and purified CD4+ and CD8+ T cells infected with LAV. Both SM and PHA supported LAV production in peripheral blood mononuclear and CD4+ cells but not in CD8+ cells. LAV production assessed by the assay of reverse transcriptase in cell supernatants appeared earlier after stimulation with SM and was 6-to 10-fold greater than after stimulation by PHA.
Purified streptococcal mitogens (SMs) including erythrogenic exotoxin were compared with phytohemagglutinin (PHA) for their ability to sustain lymphadenopathy-associated virus (LAV) replication after the stimulation of normal human peripheral blood mononuclear cells and purified CD4+ and CD8+ T cells infected with LAV. Both SM and PHA supported LAV production in peripheral blood mononuclear and CD4+ cells but not in CD8+ cells. LAV production assessed by the assay of reverse transcriptase in cell supernatants appeared earlier after stimulation with SM and was 6-to 10-fold greater than after stimulation by PHA.
The retrovirus known as lymphadenopathy-associated virus (LAV)/human T-cell lymphotropic virus type III is the etiological agent of the acquired immunodeficiency syndrome (2, 11, 18, 21, 24) . The virus is selectively cytotropic and cytopathic for the subset of T lymphocytes defined phenotypically as T4+ or Leu-3+ (CD4+) and functionally as the helper-inducer population (13, 17, 24) . These cells but not the subset of CD8+ (T8+ or Leu-2+) suppressorcytotoxic T lymphocytes are preferentially depleted in patients with acquired immunodeficiency syndrome, resulting in the reversal of the normal ratio of CD4+ to CD8+ T cells (12, 17, 24) . The 62-kilodalton surface glycoprotein T4 serves as the receptor for the virus (8, 14) .
LAV can be propagated in vitro by infection of cultured cells: unfractionated T lymphocytes from healthy virusnegative adult donors (9, 13, 18) ; separated CD4+ but not CD8+ T-cell subsets (13, 25) ; Epstein-Barr virus-transformed B lymphoblastoid cells (19) ; a T leukemia cell line (21) ; or cloned human T-cell lines (10) . The appearance of reverse transcriptase (RT) in culture supernatants indicates the presence of the retrovirus.
For significant virus production, all experiments with blood T lymphocytes require prior stimulation of these cells by phytohemagglutinin (PHA). Under these conditions, LAV production is transient and peaks between days 6 and 21 after virus infection (9, 13, 18, 19) . RT generally ranges from 3 x 104 to 10 x 104 cpm/106 cells at the peak value (average, 4 x 104 cpm).
We investigated whether other lymphocyte mitogens are able to induce LAV replication. We used streptococcal mitogens (SMs) purified from the supernatants of Streptococcus pyogenes cultures (5) to stimulate LAV-infected human T lymphocytes, both unfractionated and separated of them being erythrogenic (pyrogenic) exotoxin (16) . An SM preparation, which is active at very low concentrations (-0.1 to 1 ,ug) on T lymphocytes from various species (5), was recently shown to preferentially stimulate human CD4+ T lymphocytes through a pathway involving interleukin-2 production and its subsequent binding to interleukin-2 receptors (A. M. Korinek, E. Brisson, C. Geoffroy, J. E. Alouf, and J. C. Gluckman, submitted for publication). We have also shown that an SM preparation could be further separated by isoelectric focusing into three homogeneous mitogenic proteins named -y (pl -4.2), K (pI -4.8), and E (pI -10.3) (5). The most potent mitogen, K, was identified as the erythrogenic toxin (5). The three fractions exhibited different immunological properties with respect to the induction of mouse interferon (7) and immunomodulation and polyclonal activation of the immune response in vitro (6) .
The SM preparations used in this study were purified, with some modifications, as described elsewhere (4, 5) . The fraction collected after ammonium sulfate salting-out between 50 and 80% saturation was gel filtered on a Bio-Gel P-100 (Bio-Rad Laboratories) column (0.25 by 100 cm) equilibrated in phosphate-buffered saline (pH 6.8) instead of Sephadex G-100. The fraction corresponding to the volume eluted between 160 and 240 ml was concentrated by ultrafiltration through Amicon PM-10 membranes and constituted the purified SM preparation (2 mg of protein per ml). This preparation, submitted to preparative isoelectric focusing as previously described (4), yielded the three mitogenic fractions 'y, K, and e which after concentration contained 1.6, 1.5, and 0.5 mg of protein per ml, respectively. These fractions were homogeneous as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
LAV propagation was performed on total and fractionated T lymphocytes separated from the peripheral blood of two healthy adult donors whose serum did not contain antibodies to the virus and whose lymphocytes did not spontaneously release virus (as detected by RT activity) or express viral proteins. Peripheral blood mononuclear cells (PBM) were isolated by Ficoll-Hypaque density centrifugation and stored frozen in liquid nitrogen as previously described (15, 18) .
Before use, the cells were thawed in a water bath at 37C, washed once, and incubated at 37°C in culture medium for 1 h before being counted and adjusted to appropriate concentrations (14, 18) . Suspensions of enriched T lymphocytes were obtained after the depletion of monocytes by plastic adherence and by rosetting with aminoethylisothiuroniumtreated sheep erythrocytes, followed by centrifugation on a Ficoll-Hypaque gradient (13) . On the average, T cellenriched suspensions contained more than 90% T lymphocytes, with 5 to 7% contaminating cells, while non-T-cell preparations (NT) comprised 5 to 6% T cells and a mixture of approximately equal numbers of B cells and monocytes. Purified CD4+ and CD8+ T lymphocytes were obtained by cellular affinity chromatography as previously described (13) .
Virus infection of target cells was done as previously described (13), with some modifications. Briefly, 5 x 106 cells were cultured at 37°C in 5% CO2 in the presence of either 1% PHA-M (Difco Laboratories) or various concentrations of a purified SM preparation or 'y, K, and e fractions in RPMI 1640 medium (GIBCO Diagnostics) supplemented with 10% fetal bovine serum. After 3 days, the cells were sedimented and suspended in mitogen-free medium containing interleukin-2, anti--y interferon serum, and Polybrene (2). The LAV preparation (5,000 cpm of RT-containing supernatant per 106 cells to be infected) was added. After 3 days, the cells were centrifuged to remove the unadsorbed virus and resuspended in culture medium. The cells were sedimented and suspended in fresh medium every 3 days. RT activity was determined in the cell supernatants as described elsewhere (2) .
A microculture proliferation assay of the various lymphocyte preparations challenged with SMs ( Fig. 1) showed that helper-inducer CD4+ lymphocytes were preferentially stimulated as compared with CD8+ lymphocytes. Stimulation required the presence of accessory non-T cells (NT), in agreement with a recent detailed study of SM interaction with human lymphocytes (Korinek et al., submitted).
The total RT activity released between days 6 and 15 from a virus-infected PBM suspension which had been stimulated with SMs was three-to fivefold greater (2 x 105 to 4 x 105 cpm) than that released from the PBM suspension activated by PHA. Optimal RT activity appeared earlier (day 6) than with PHA (day 9), and it decreased less rapidly. When challenged by SMs (Fig. 2) , isolated CD4+ T cells or a mixture of purified CD4+ and CD8+ subsets showed a much higher (up to 10-fold) RT 
